Publication | Closed Access
Effects of SR140333, a selective non‐peptide NK<sub>1</sub> receptor antagonist, on trigemino‐thalamic nociceptive pathways in the rat
15
Citations
41
References
1998
Year
Pain MedicineImmunologyNeuropathic PainMolecular PainMolecular PharmacologyTrigemino‐thalamic Nociceptive PathwaysNeurochemistryHealth SciencesNeuropharmacologyTrigeminal StimulationNervous SystemPharmacologyPain ResearchNeurophysiologyPhysiologyNeuropeptide ReceptorNk2 Receptor AntagonistsNeurosciencePain MechanismCentral Nervous SystemMedicineC-fos Expression
Trigeminal stimulation of C-fibers increased c-fos expression within the trigeminal nucleus caudalis (NtV) and thalamic neuronal activity which both reflect the transmission of a nociceptive message. We examined the effects on both these phenomena of the selective NK1 and NK2 receptor antagonists, SR140333 and SR48968. SR140333 (0.3, 1 and 3 micrograms/kg intravenously [i.v.]) dose-dependently, reversibly and stereoselectively antagonized the increase of contralateral thalamic activity. This compound, when given i.v. (30 micrograms/kg) or orally (10 mg/kg), also reduced the number of Fos-like immunoreactive cells particularly at the medial and caudal level of the NtV. In contrast, SR48968 did not exert any antagonistic effect either on thalamic activity or on Fos-like immunoreactivity. The data strongly suggest a preferential involvement of NK1 vs NK2 receptors in nociceptive transmission following trigeminal ganglion stimulation. Taken together, our results indicate that SR140333 could provide a potent drug for the relief of pain occurring under excessive activity of sensory trigeminal fibers.
| Year | Citations | |
|---|---|---|
Page 1
Page 1